Sphingosine kinase and sphingosine 1-phosphate in asthma

Bioscience Reports

Volumn 31, Issue 2, 2011, Pages 145-150

  Lai, Wen Qi ^a   Wong, W S Fred ^a   Leung, Bernard P ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Asthma; Cytokine; Inflammation; Sphingolipid; Sphingosine 1 phosphate (S1P); Sphingosine kinase (SphK)

Indexed keywords

BETA1A INTERFERON; FINGOLIMOD; FYT 720; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; UNCLASSIFIED DRUG; ANTIASTHMATIC AGENT; CYTOKINE; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; PROPANEDIOL DERIVATIVE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE;

ASTHMA; BREATHING MUSCLE; DISEASE MODEL; HUMAN; LUNG ALVEOLUS EPITHELIUM; MAST CELL; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; EPITHELIUM CELL; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; MOUSE;

EUKARYOTA;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; INFLAMMATION; LUNG; LYSOPHOSPHOLIPIDS; MAST CELLS; MICE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROPYLENE GLYCOLS; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOSINE;

EID: 79952480429     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSR20100087     Document Type: Review

References (53)

1. Spiegel, S. and Milstien, S. (2003) Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat. Rev. Mol. Cell Biol. 4, 397-407
2. Melendez, A. J., Carlos-Dias, E., Gosink, M., Allen, J. M. and Takacs, L. (2000) Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 251, 19-26 (Pubitemid 30339413)
3. Pitson, S. M., D'Andrea, J. R., Vandeleur, L., Moretti, P. A., Xia, P., Gamble, J. R., Vadas, M. A. and Wattenberg, B. W. (2000) Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem. J. 350, 429-441
4. Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T. and Spiegel, S. (2000) Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275, 19513-19520
5. Sanchez, T. and Hla, T. (2004) Structural and functional characteristics of SlP receptors. J. Cell. Biochem. 92, 913-922
6. Tay, H. K., Vit, P. and Melendez, A. J. (2005) Sphingosine kinase signalling in immune cells. Clin. Exp. Pharmacol. Physiol. 32, 153-161
7. Melendez, A. J. (2008) Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets. Biochim. Biophys. Acta 1784, 66-75
8. Caramori, G., Groneberg, D., Ito, K., Casolari, P., Adcock, I. M. and Papi, A. (2008) New drugs targeting Th2 lymphocytes in asthma. J. Occup. Med. Toxicol. 3 (Suppl. 1), S6
9. Murphy, D. M. and O'Byrne, P. M. (2010) Recent advances in the pathophysiology of asthma. Chest 137, 1417-1426
10. Holgate, S. T. (2007) Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 120, 1233-1244
11. Holgate, S. T. (2008) Pathogenesis of asthma. Clin. Exp. Allergy. 38, 872-897
12. Brown, J. M., Wilson, T. M. and Metcalfe, D. D. (2008) The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 38, 4-18
13. 2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am. Rev. Respir. Dis. 142, 126-132
14. Choi, O. H., Kim, J. H. and Kinet, J. P. (1996) Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor. Nature 380, 634-636 (Pubitemid 26119017)
15. 2+ mobilization via a sphingosine kinase pathway in a clathrin-dependent manner. Cell Calcium 45, 99-108
16. Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E. and Baumruker, T. (1999) The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fcε receptor I triggering. J. Exp. Med. 190, 1-8
17. 2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem. 277, 17255-17262
18. Oskeritzian, C. A., Alvarez, S. E., Hait, N. C., Price, M. M., Milstien, S. and Spiegel, S. (2008) Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. Blood 111, 4193-4200
19. Jolly, P. S., Bektas, M., Olivera, A., Gonzalez-Espinosa, C., Proia, R. L., Rivera, J., Milstien, S. and Spiegel, S. (2004) Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199, 959-970
20. Yokoo, E., Yatomi, Y., Takafuta, T., Osada, M., Okamoto, Y. and Ozaki, Y. (2004) Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells. J. Biochem. (Tokyo) 135, 673-681
21. Olivera, A., Mizugishi, K., Tikhonova, A., Ciaccia, L., Odom, S., Proia, R. L. and Rivera, J. (2007) The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26, 287-297 (Pubitemid 46413904)
22. Beck-Schimmer, B., Schimmer, R. C., Warner, R. L., Schmal, H., Nordblom, G., Flory, C. M., Lesch, M. E., Friedl, H. P., Schrier, D. J. and Ward, P.A (1997) Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am. J. Respir. Cell. Mol. Biol. 17, 344-352
23. Lazaar, A. L., Albelda, S. M., Pilewski, J. M., Brennan, B., Pure, E. and Panettieri, R. A. (1994) T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J. Exp. Med. 180, 807-816
24. Hughes, J. M., Arthur, C. A., Baracho, S., Carlin, S. M., Hawker, K. M., Johnson, P. R. and Armour, C. L. (2000) Human eosinophil-airway smooth muscle cell interactions. Mediators Inflamm. 9, 93-99
25. Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J. and Pavord, I. D. (2002) Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346, 1699-1705
26. De, S., Zelazny, E. T., Souhrada, J. F. and Souhrada, M. (1995) IL-1β and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. J. Appl. Physiol. 78, 1555-1563
27. Hakonarson, H., Maskeri, N., Carter, C., Chuang, S. and Grunstein, M. M. (1999) Autocrine interaction between IL-5 and IL-1β mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 104, 657-667
28. Saunders, M. A., Mitchell, J. A., Seldon, P. M., Yacoub, M. H., Barnes, P. J., Giembycz, M. A. and Belvisi, M. G. (1997) Release of granulocyte- macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br. J. Pharmacol. 120, 545-546
29. Li, D., Wang, D., Griffiths-Johnson, D. A., Wells, T. N., Williams, T. J., Jose, P. J. and Jeffery, P. K. (1997) Eotaxin protein and gene expression in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. Eur. Respir. J. 10, 1946-1954
30. Sousa, A. R., Lane, S. J., Nakhosteen, J. A., Yoshimura, T., Lee, T. H. and Poston, R. N. (1994) Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am. J. Respir. Cell. Mol. Biol. 10, 142-147
31. Berkman, N., Krishnan, V. L., Gilbey, T., Newton, R., O'Connor, B., Barnes, P. J. and Chung, K. F. (1996) Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am. J. Respir. Crit. Care Med. 154, 1804-1811
32. Pfaff, M., Powaga, N., Akinci, S., Schutz, W., Banno, Y., Wiegand, S., Kummer, W., Wess, J. and Haberberger, R. V. (2005) Activation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways. Respir. Res. 6, 48
33. Ammit, A. J., Hastie, A. T., Edsall, L. C., Hoffman, R. K., Amrani, Y., Krymskaya, V. P., Kane, S. A., Peters, S. P., Penn, R. B., Spiegel, S. and Panettieri, R. A. (2001) Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodelling in asthma. FASEB. J. 15, 1212-1214
34. Rosenfeldt, H. M., Amrani, Y., Watterson, K. R., Murthy, K. S., Panettieri, Jr, R. A. and Spiegel, S. (2003) Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB. J. 17, 1789-1799 (Pubitemid 37214773)
35. Kume, H., Takeda, N., Oguma, T., Ito, S., Kondo, M., Ito, Y. and Shimokata, K. (2007) Sphingosine 1-phosphate causes airway hyper-reactivity by rho-mediated myosin phosphatase inactivation. J. Pharmacol. Exp. Ther. 320, 766-773
36. Roviezzo, F., Di Lorenzo, A., Bucci, M., Brancaleone, V., Vellecco, V., De Nardo, M., Orlotti, D., De Palma, R., Rossi, F., D'Agostino, B. and Cirino, G. (2007) Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. Am. J. Respir. Cell. Mol. Biol. 36, 757-762
37. Holgate, S. T., Roberts, G., Arshad, H. S., Howarth, P. H. and Davies, D. E. (2009) The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc. Am. Thorac. Soc. 6, 655-659
38. Holgate, S. T. (2008) The airway epithelium is central to the pathogenesis of asthma. Allergol. Int. 57, 1-10
39. Chen, L. Y., Woszczek, G., Nagineni, S., Logun, C. and Shelhamer, J. H. (2008) Cytosolic phospholipase A2α activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L326-L335
40. Kono, Y., Nishiuma, T., Okada, T., Kobayashi, K., Funada, Y., Kotani, Y., Jahangeer, S., Nakamura, S. and Nishimura, Y. (2010) Sphingosine kinase 1 regulates mucin production via ERK phosphorylation. Pulm. Pharmacol. Ther. 23, 36-42
41. Lai, W. Q., Goh, H. H., Bao, Z., Wong, W. S., Melendez, A. J. and Leung, B. P. (2008) The role of sphingosine kinase in a murine model of allergic asthma. J. Immunol. 180, 4323-4329
42. Xia, P., Gamble, J. R., Rye, K. A., Wang, L., Hii, C. S., Cockerill, P., Khew-Goodall, Y., Bert, A. G., Barter, P. J. and Vadas, M. A. (1998) Tumour necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 95, 14196-14201
43. Edsall, L. C., Van Brooklyn, J. R., Cuvillier, O., Kleuser, B. and Spiegel, S. (1998) N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 37, 12892-12898 (Pubitemid 28433522)
44. Kunisawa, J., Kurashima, Y., Gohda, M., Higuchi, M., Ishikawa, I., Miura, F., Ogahara, I. and Kiyono, H. (2007) Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production. Blood 109, 3749-3756 (Pubitemid 46641725)
45. Nishiuma, T., Nishimura, Y., Okada, T., Kuramoto, E., Kotani, Y., Jahangeer, S. and Nakamura, S. (2008) Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L1085-L1093
46. Roviezzo, F., D'Agostino, B., Brancaleone, V., De Gruttola, L., Bucci, M., De Dominicis, G., Orlotti, D., D'Aiuto, E., De Palma, R., Rossi, F. et al. (2010) Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse. Am. J. Respir. Cell. Mol. Biol. 42, 572-577
47. Zemann, B., Kinzel, B., Muller, M., Reuschel, R., Mechtcheriakova, D., Urtz, N., Bornancin, N., Baumruker, T. and Billich, A. (2006) Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 107, 1454-1458 (Pubitemid 43242381)
48. Mansoor, M. and Melendez, A. J. (2008) Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine. Rev. Recent Clin. Trials 3, 62-69
49. Brinkmann, V. (2009) FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br. J. Pharmacol. 158, 1173-1182
50. Okazaki, H., Hirata, D., Kamimura, T., Sato, H., Iwamoto, M., Yoshio, T., Masuyama, J., Fujimura, A., Kobayashi, E., Kano, S. and Minota, S. (2002) Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. J. Rheumatol. 29, 707-716 (Pubitemid 34303864)
51. Cohen, J. A., Barkhof, F., Comi, G., Hartung, H. P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G. et al. (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362, 402-415
52. Idzko, M., Hammad, H., van Nimwegen, M., Kool, M., Muller, T., Soullie, T., Willart, M. A., Hijdra, D., Hoogsteden, H. C. and Lambrecht, B. N. (2006) Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest. 116, 2935-2944
53. Sawicka, E., Zuany-Amorim, C., Manlius, C., Trifilieff, A., Brinkmann, V., Kemeny, D. M. and Walker, C. (2003) Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J. Immunol. 171, 6206-6214 (Pubitemid 37467244)